Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Apr;34(4):810–815. doi: 10.1128/jcm.34.4.810-815.1996

Validation of nested Bordetella PCR in pertussis vaccine trial.

E Reizenstein 1, L Lindberg 1, R Möllby 1, H O Hallander 1
PMCID: PMC228897  PMID: 8815088

Abstract

A nested PCR, using a 239-bp sequence in the pertussis toxin promoter region, was developed and evaluated. The assay differentiates Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica by restriction enzyme analysis of the amplified fragments. The diagnostic performance of the PCR was evaluated in a Swedish pertussis vaccine efficacy trial which took place from 1992 to 1995, including study children and household members and using culture and serology for laboratory confirmation of suspected cases. In total 2,421 nasopharyngeal aspirates were analyzed. The total diagnostic sensitivity for B. pertussis was 90.2% (194 of 215). During the study period samples were processed with and without the cation-exchange resin Chelex. The PCR diagnostic sensitivity for B. pertussis among the Chelex-treated aspirates was 94.9% (75 of 79), and that for B. pertussis among 124 aspirates in a consecutive non-Chelex-treated material was 89.5% (111 of 124). After Chelex treatment of the 13 PCR-negative samples, an additional six became PCR positive, giving a final sensitivity of 94.3%. In addition, PCR was positive for B. pertussis with 57 of 1,744 samples negative by culture but with available serological data. The specificity of PCR with these samples was supported by a significant increase in antibody levels between acute and convalescent sera in 45 cases and by epidemiological or clinical data in all but two of the remaining cases. PCR was also positive for B. pertussis with 26 of 415 aspirates from episodes lacking serology. The diagnostic sensitivity of PCR for B. parapertussis was 74.0% (37 of 50). There were an additional seven culture-negative B. parapertussis PCR findings, six from cases with significant antibody increases against filamentous hemagglutinin only and one from a case lacking serology. There were no samples positive for B. bronchiseptica. In conclusion, PCR detection of B. pertussis and/or B. parapertussis enabled us to identify 90 positive nasopharyngeal aspirates, in addition to the 262 culture-positive samples (an increase of 34%). Relating these cases to serology and clinical data indicated a PCR specificity approaching 100%.

Full Text

The Full Text of this article is available as a PDF (206.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cimolai N., Trombley C. Insertional sequence primers for Bordetella pertussis diagnostic polymerase chain reaction differentiate strains of Pseudomonas cepacia. J Infect Dis. 1995 Jul;172(1):293–295. doi: 10.1093/infdis/172.1.293. [DOI] [PubMed] [Google Scholar]
  2. Douglas E., Coote J. G., Parton R., McPheat W. Identification of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cyclase gene. J Med Microbiol. 1993 Feb;38(2):140–144. doi: 10.1099/00222615-38-2-140. [DOI] [PubMed] [Google Scholar]
  3. Glare E. M., Paton J. C., Premier R. R., Lawrence A. J., Nisbet I. T. Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. J Clin Microbiol. 1990 Sep;28(9):1982–1987. doi: 10.1128/jcm.28.9.1982-1987.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Granström G., Wretlind B., Granström M. Diagnostic value of clinical and bacteriological findings in pertussis. J Infect. 1991 Jan;22(1):17–26. doi: 10.1016/0163-4453(91)90842-g. [DOI] [PubMed] [Google Scholar]
  5. Grimprel E., Bégué P., Anjak I., Betsou F., Guiso N. Comparison of polymerase chain reaction, culture, and western immunoblot serology for diagnosis of Bordetella pertussis infection. J Clin Microbiol. 1993 Oct;31(10):2745–2750. doi: 10.1128/jcm.31.10.2745-2750.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gustafsson L., Hallander H. O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996 Feb 8;334(6):349–355. doi: 10.1056/NEJM199602083340602. [DOI] [PubMed] [Google Scholar]
  7. Hallander H. O., Reizenstein E., Renemar B., Rasmuson G., Mardin L., Olin P. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J Clin Microbiol. 1993 Jan;31(1):50–52. doi: 10.1128/jcm.31.1.50-52.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hallander H. O., Storsaeter J., Möllby R. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J Infect Dis. 1991 May;163(5):1046–1054. doi: 10.1093/infdis/163.5.1046. [DOI] [PubMed] [Google Scholar]
  9. He Q., Mertsola J., Soini H., Skurnik M., Ruuskanen O., Viljanen M. K. Comparison of polymerase chain reaction with culture and enzyme immunoassay for diagnosis of pertussis. J Clin Microbiol. 1993 Mar;31(3):642–645. doi: 10.1128/jcm.31.3.642-645.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Houard S., Hackel C., Herzog A., Bollen A. Specific identification of Bordetella pertussis by the polymerase chain reaction. Res Microbiol. 1989 Sep;140(7):477–487. doi: 10.1016/0923-2508(89)90069-7. [DOI] [PubMed] [Google Scholar]
  11. Li Z., Jansen D. L., Finn T. M., Halperin S. A., Kasina A., O'Connor S. P., Aoyama T., Manclark C. R., Brennan M. J. Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol. 1994 Mar;32(3):783–789. doi: 10.1128/jcm.32.3.783-789.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Locht C., Keith J. M. Pertussis toxin gene: nucleotide sequence and genetic organization. Science. 1986 Jun 6;232(4755):1258–1264. doi: 10.1126/science.3704651. [DOI] [PubMed] [Google Scholar]
  13. Meade B. D., Bollen A. Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. J Med Microbiol. 1994 Jul;41(1):51–55. doi: 10.1099/00222615-41-1-51. [DOI] [PubMed] [Google Scholar]
  14. Niederhauser C., Höfelein C., Wegmüller B., Lüthy J., Candrian U. Reliability of PCR decontamination systems. PCR Methods Appl. 1994 Oct;4(2):117–123. doi: 10.1101/gr.4.2.117. [DOI] [PubMed] [Google Scholar]
  15. Olcén P., Bäckman A., Johansson B., Esbjörner E., Törnqvist E., Bygraves J., McPheat W. L. Amplification of DNA by the polymerase chain reaction for the efficient diagnosis of pertussis. Scand J Infect Dis. 1992;24(3):339–345. doi: 10.3109/00365549209061340. [DOI] [PubMed] [Google Scholar]
  16. Onorato I. M., Wassilak S. G. Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J. 1987 Feb;6(2):145–151. doi: 10.1097/00006454-198702000-00002. [DOI] [PubMed] [Google Scholar]
  17. Regan J., Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol. 1977 Sep;6(3):303–309. doi: 10.1128/jcm.6.3.303-309.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Reizenstein E., Hallander H. O., Blackwelder W. C., Kühn I., Ljungman M., Möllby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods. 1995 Jun 28;183(2):279–290. doi: 10.1016/0022-1759(95)00067-k. [DOI] [PubMed] [Google Scholar]
  19. Reizenstein E., Johansson B., Mardin L., Abens J., Möllby R., Hallander H. O. Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchiseptica. Diagn Microbiol Infect Dis. 1993 Oct;17(3):185–191. doi: 10.1016/0732-8893(93)90094-n. [DOI] [PubMed] [Google Scholar]
  20. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  21. Schläpfer G., Cherry J. D., Heininger U., Uberall M., Schmitt-Grohé S., Laussucq S., Just M., Stehr K. Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Pediatr Infect Dis J. 1995 Mar;14(3):209–214. doi: 10.1097/00006454-199503000-00008. [DOI] [PubMed] [Google Scholar]
  22. Stark M., Reizenstein E., Uhlén M., Lundeberg J. Immunomagnetic separation and solid-phase detection of Bordetella pertussis. J Clin Microbiol. 1996 Apr;34(4):778–784. doi: 10.1128/jcm.34.4.778-784.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Vandamme P., Hommez J., Vancanneyt M., Monsieurs M., Hoste B., Cookson B., Wirsing von König C. H., Kersters K., Blackall P. J. Bordetella hinzii sp. nov., isolated from poultry and humans. Int J Syst Bacteriol. 1995 Jan;45(1):37–45. doi: 10.1099/00207713-45-1-37. [DOI] [PubMed] [Google Scholar]
  24. Weyant R. S., Hollis D. G., Weaver R. E., Amin M. F., Steigerwalt A. G., O'Connor S. P., Whitney A. M., Daneshvar M. I., Moss C. W., Brenner D. J. Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol. 1995 Jan;33(1):1–7. doi: 10.1128/jcm.33.1.1-7.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. van der Zee A., Agterberg C., van Agterveld M., Peeters M., Mooi F. R. Characterization of IS1001, an insertion sequence element of Bordetella parapertussis. J Bacteriol. 1993 Jan;175(1):141–147. doi: 10.1128/jb.175.1.141-147.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES